Published in Eur Arch Otorhinolaryngol on May 13, 2005
Generation of reactive oxygen species by grape seed extract causes irreparable DNA damage leading to G2/M arrest and apoptosis selectively in head and neck squamous cell carcinoma cells. Carcinogenesis (2012) 0.92
FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev (2010) 0.84
Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis (2009) 0.84
European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol (2014) 0.83
High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma. Biomed Res Int (2014) 0.80
Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas. Clin Oral Investig (2015) 0.77
Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma. Cancer Med (2016) 0.76
Grape seed extract targets mitochondrial electron transport chain complex III and induces oxidative and metabolic stress leading to cytoprotective autophagy and apoptotic death in human head and neck cancer cells. Mol Carcinog (2014) 0.75
First Clinical Report on Comparative Treatment and Survival Outcomes in Second Cancers after Primary Head and Neck Cancer: A Population-Based Study. Cureus (2017) 0.75
Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45
Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer (1995) 2.47
Second neoplasm in patients with head and neck cancer. Head Neck (1999) 1.62
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope (2001) 1.59
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev (2001) 1.50
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control (2003) 1.39
Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg (1994) 1.12
Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer (2002) 0.99
Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy. J Laryngol Otol (2002) 0.93
Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst (1990) 0.92
Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck (1999) 0.89
Second malignant neoplasia in patients with T1 glottic cancer treated with radiation. Laryngoscope (1998) 0.87
Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord. Ann Otol Rhinol Laryngol (2002) 0.84
Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor. Lab Invest (1995) 0.83
Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol (2007) 2.30
Second, third, and fourth head and neck tumors. A progressive decrease in survival. Head Neck (2012) 1.97
The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer (2004) 1.63
Lymphadenopathy caused by Mycobacterium colombiense. J Clin Microbiol (2008) 1.20
Hypothyroidism in patients treated with total laryngectomy. A multivariate study. Eur Arch Otorhinolaryngol (2002) 1.02
Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2. J Lipid Res (2012) 1.01
Variability in nerve patterns of the adductor muscle group supplied by the recurrent laryngeal nerve. Laryngoscope (2005) 0.99
Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma. JAMA Otolaryngol Head Neck Surg (2013) 0.96
Is the external laryngeal nerve an exclusively motor nerve? The cricothyroid connection branch. Laryngoscope (2003) 0.96
The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy. Radiother Oncol (2003) 0.94
Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control (2008) 0.94
Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. Int J Cancer (2008) 0.93
Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma. Head Neck (2005) 0.90
Prostaglandin E(2) pathway in head and neck squamous cell carcinoma. Head Neck (2008) 0.89
Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society. Eur Arch Otorhinolaryngol (2009) 0.89
Supracricoid laryngectomy as salvage surgery after failure of radiation therapy. Eur Arch Otorhinolaryngol (2007) 0.83
Variability of the nerve supply patterns of the human posterior cricoarytenoid muscle. Laryngoscope (2003) 0.83
Incidence and significance of clinically unsuspected thyroid tissue in lymph nodes found during neck dissection in head and neck carcinoma patients. Laryngoscope (2005) 0.83
European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol (2014) 0.83
High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma. Cancer Med (2013) 0.82
Parotidectomies in benign parotid tumours: "Sant Pau" surgical extension classification. Acta Otorrinolaringol Esp (2009) 0.82
Risk of third and fourth tumors in patients with head and neck cancer. Head Neck (2010) 0.81
Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy. J Pathol (2015) 0.81
Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy. Head Neck (2012) 0.81
Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy. Oral Oncol (2012) 0.80
Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation. Diagn Mol Pathol (2005) 0.80
Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway. J Clin Endocrinol Metab (2013) 0.80
Potential structures that could be confused with a nonrecurrent inferior laryngeal nerve: an anatomic study. Laryngoscope (2008) 0.79
Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma. Eur Arch Otorhinolaryngol (2004) 0.79
Development and (pre-) clinical assessment of a novel surgical tool for primary and secondary tracheoesophageal puncture with immediate voice prosthesis insertion, the Provox Vega Puncture Set. Eur Arch Otorhinolaryngol (2012) 0.78
[Two cases of intraparotid facial nerve schwannoma]. Acta Otorrinolaringol Esp (2010) 0.78
[Diagnosis and treatment of functional oropharyngeal dysphagia. Features of interest to the digestive surgeon]. Cir Esp (2007) 0.78
Reconstruction of a perianal defect by means of a bilateral V-Y advancement flap based on the perforating arteries of the gluteus maximus shaped over a cicatricial area. J Plast Reconstr Aesthet Surg (2008) 0.78
[A prospective, multicentre study on the activity of general and digestive surgery residents based on the use of the computerised logbook]. Cir Esp (2012) 0.77
Comparison of chi-squared automatic interaction detection classification trees vs TNM classification for patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2012) 0.77
Ceratocricoid muscle: an embryological and anatomical study. Clin Anat (2009) 0.77
Total or subtotal glossectomy with microsurgical reconstruction: functional and oncological results. Microsurgery (2011) 0.76
[Larynx transplant: a therapeutic option for the 21st century? Literature review]. Acta Otorrinolaringol Esp (2008) 0.75
External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. Head Neck (2007) 0.75
Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification. Head Neck (2008) 0.75
Elective treatment of the neck for second primary tumors of the head and neck. Eur Arch Otorhinolaryngol (2013) 0.75
Is dissection of level V necessary in patients with T(2)-T(4)N(0) supraglottic cancer? J Laryngol Otol (2004) 0.75
Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced pyriform sinus carcinoma. Eur Arch Otorhinolaryngol (2002) 0.75
[Results of an organ conservation protocol in patients with locally advanced laryngeal tumours]. Acta Otorrinolaringol Esp (2009) 0.75